Martin S Maron Selected Research

Sudden Death

1/2022	Importance of newer cardiac magnetic resonance-based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study.
1/2022	Cats Have Nine Lives but This Hypertrophic Cardiomyopathy Patient Has Had Ten (So Far).
1/2022	Characteristics of Patients With Obstructive Hypertrophic Cardiomyopathy in Real-World Community-Based Cardiovascular Practices.
1/2022	Hypertrophic Cardiomyopathy: New Concepts and Therapies.
1/2022	Management of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review.
10/2021	Cardiovascular Diseases That Have Emerged From the Darkness.
1/2021	Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator.
10/2020	Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants.
11/2019	Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
1/2019	Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin S Maron Research Topics

Disease

45	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022 - 08/2006
30	Sudden Death 01/2022 - 07/2006
27	Heart Failure 01/2022 - 11/2004
17	Ventricular Tachycardia 01/2022 - 01/2012
16	Fibrosis (Cirrhosis) 03/2021 - 08/2009
9	Cicatrix (Scar) 01/2022 - 10/2008
7	Disease Progression 01/2022 - 01/2012
6	Ventricular Fibrillation 01/2022 - 02/2008
6	Left Ventricular Outflow Obstruction 01/2022 - 08/2006
5	Atrial Fibrillation 01/2022 - 01/2013
5	Embolic Stroke 01/2022 - 01/2013
5	Aneurysm (Aneurysms) 01/2022 - 10/2008
5	Heart Arrest (Cardiac Arrest) 10/2020 - 02/2013
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2012
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 01/2019
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2017
3	Hypertrophy 07/2012 - 01/2011
2	Shock 10/2021 - 02/2008
2	Stroke (Strokes) 01/2021 - 10/2008
2	Ventricular Remodeling 01/2018 - 07/2010
2	Takotsubo Cardiomyopathy 02/2009 - 06/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Coronary Disease (Coronary Heart Disease) 10/2021
1	Hypotension (Low Blood Pressure) 10/2021
1	Pulmonary Arterial Hypertension 10/2021
1	Amyloidosis 10/2021
1	Inflammation (Inflammations) 03/2021
1	Chest Pain (Chest Pains) 10/2020
1	Rupture 10/2020
1	Nausea 10/2020
1	Vomiting 10/2020
1	Tachycardia (Tachyarrhythmias) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2019
1	Channelopathies 01/2019
1	Fabry Disease (Fabry's Disease) 01/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2018
1	Heart Diseases (Heart Disease) 02/2016
1	Out-of-Hospital Cardiac Arrest 01/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2013
1	Body Weight (Weight, Body) 01/2011
1	Ischemia 12/2009
1	Left Ventricular Dysfunction 08/2009
1	Anterior Wall Myocardial Infarction 06/2008
1	Myocardial Infarction 06/2008

Drug/Important Bio-Agent (IBA)

25	GadoliniumIBA 01/2022 - 10/2008
9	Pharmaceutical PreparationsIBA 01/2022 - 11/2004
4	Biomarkers (Surrogate Marker)IBA 03/2021 - 01/2011
3	MYK-461IBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
3	TroponinIBA 10/2021 - 06/2008
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	CollagenIBA 01/2018 - 01/2011
1	Vasopressins (Vasopressin)IBA 10/2021
1	tafamidisIBA 10/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 10/2021
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2021
1	Prealbumin (Transthyretin)IBA 10/2021
1	EicosanoidsIBA 03/2021
1	CalciumIBA 03/2021
1	Blood Proteins (Serum Proteins)IBA 03/2021
1	Biological ProductsIBA 03/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Janus KinasesIBA 01/2021
1	LipidsIBA 01/2019
1	GalactosidasesIBA 01/2018
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2018
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 02/2017
1	myosin-binding protein CIBA 02/2017
1	SodiumIBA 03/2016
1	ForminsIBA 02/2013
1	Gadolinium DTPA (Magnevist)FDA Link 01/2011
1	Dipyridamole (Persantine)FDA LinkGeneric 08/2009
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2009

Therapy/Procedure

34	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 10/2008
24	Therapeutics 01/2022 - 07/2009
14	Defibrillators (Defibrillator) 01/2022 - 07/2006
6	Heart Transplantation (Grafting, Heart) 01/2018 - 07/2006
3	Intravenous Administration 10/2021 - 12/2009
3	Secondary Prevention 01/2019 - 02/2013
2	Drug Therapy (Chemotherapy) 10/2021 - 10/2021
2	Radiofrequency Ablation 01/2017 - 01/2013
2	Catheters 07/2014 - 11/2004
2	Induced Hypothermia 01/2012 - 06/2011
1	Ablation Techniques 01/2022
1	Precision Medicine 01/2021
1	Maze Procedure 01/2020
1	Cardiac Resynchronization Therapy 01/2019
1	Enzyme Replacement Therapy 01/2018
1	Heart-Assist Devices 01/2018
1	Resuscitation 01/2017
1	Transplantation 02/2013